Effects of long-term administration of interferon α in two models of liver fibrosis in rats
Authors:
- Christophe PiletteCPChristophe Pilette
- Nary VealNVNary Veal
- Frédéric ObertiFOFrédéric Oberti
- Yves GalloisYGYves Gallois
- Olivier DouayODOlivier Douay
- Jean RosenbaumJRJean Rosenbaum
- Paul CalèsPCPaul Calès
- 1 August 1998
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (2) , 263-270
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligationJournal of Hepatology, 1997
- Prevention of portal hypertension by propanolol and spironolactone in rats with bile duct ligationJournal of Hepatology, 1997
- The Cellular Pathogenesis of Portal Hypertension: Stellate Cell Contractility, Endothelin, and Nitric OxideHepatology, 1997
- Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosisHepatology, 1996
- Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyteJournal of Hepatology, 1995
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993
- Inhibition of Rat Hepatic Lipocyte Activation in Culture by Interferon–γHepatology, 1992
- Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitroJournal of the American Academy of Dermatology, 1989
- Persistence of a reduced-collagen-producing phenotype in cultured scleroderma fibroblasts after short-term exposure to interferons.Journal of Clinical Investigation, 1987
- The Porto-Systemic Collateral Pattern in the RatEuropean Surgical Research, 1974